PRKAG2 and disorder of glycogen metabolism: There are hints, for example, that the alglucosidase-alfa enzyme replacement therapy used for the treatment of patients with Morbus Pompe might also be beneficial for patients with PRKAG2-associated glycogen storage disease [38].